Mechanisms of Apoptosis-Related Long Non-coding RNAs in Ovarian Cancer

被引:12
作者
Takeiwa, Toshihiko [1 ]
Ikeda, Kazuhiro [1 ]
Horie-Inoue, Kuniko [1 ]
Inoue, Satoshi [1 ,2 ]
机构
[1] Saitama Med Univ, Div Syst Med & Gene Therapy, Saitama, Japan
[2] Tokyo Metropolitan Inst Gerontol, Dept Syst Aging Sci & Med, Tokyo, Japan
基金
日本学术振兴会;
关键词
ovarian cancer; ovary; apoptosis; long non-coding RNA; transcriptional regulation; histone modification complex; competing endogenous RNA; FACTOR-KAPPA-B; CELL-PROLIFERATION; PACLITAXEL RESISTANCE; LNCRNA NEAT1; PROMOTES; EXPRESSION; HOTAIR; PROGRESSION; SYSTEM; MODULATORS;
D O I
10.3389/fcell.2021.641963
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Ovarian cancer is a health-threatening malignancy of ovary in female reproductive systems and one of the most common gynecological malignancies worldwide. Due to rare early symptoms, ovarian cancers are often diagnosed at advanced stages and exhibit poor prognosis. Thus, efforts have been paid to develop alternative diagnostic and therapeutic strategies for the disease. Recent studies have presented that some long non-coding RNAs (lncRNAs) play roles in apoptosis of ovarian cancer cells through various mechanisms involved in the regulation of transcription factors, histone modification complexes, miRNAs, and protein stability. Because evasion of apoptosis in cancer cells facilitates to promote tumor progression and therapy resistance, apoptosis regulatory mechanisms of lncRNAs may be promising new targets in ovarian cancer. In this review, we introduce the recent findings in regard to the molecular mechanisms of apoptosis-related lncRNAs in ovarian cancer cells.
引用
收藏
页数:9
相关论文
共 83 条
[1]   Recent Advances in Nanoparticle-Based Cancer Drug and Gene Delivery [J].
Amreddy, Narsireddy ;
Babu, Anish ;
Muralidharan, Ranganayaki ;
Panneerselvam, Janani ;
Srivastava, Akhil ;
Ahmed, Rebaz ;
Mehta, Meghna ;
Munshi, Anupama ;
Ramesh, Rajagopal .
ADVANCES IN CANCER RESEARCH, VOL 137, 2018, 137 :115-170
[2]   LncRNA NEAT1 contributes to paclitaxel resistance of ovarian cancer cells by regulating ZEB1 expression via miR-194 [J].
An, Jihong ;
Lv, Weiling ;
Zhang, Yongzhou .
ONCOTARGETS AND THERAPY, 2017, 10 :5377-5390
[3]   Therapeutic Targeting of Long Non-Coding RNAs in Cancer [J].
Arun, Gayatri ;
Diermeier, Sarah D. ;
Spector, David L. .
TRENDS IN MOLECULAR MEDICINE, 2018, 24 (03) :257-277
[4]   Ovarian Cancer Cell Line Panel (OCCP): Clinical Importance of In Vitro Morphological Subtypes [J].
Beaufort, Corine M. ;
Helmijr, Jean C. A. ;
Piskorz, Anna M. ;
Hoogstraat, Marlous ;
Ruigrok-Ritstier, Kirsten ;
Besselink, Nicolle ;
Murtaza, Muhammed ;
van IJcken, Wilfred F. J. ;
Heine, Anouk A. J. ;
Smid, Marcel ;
Koudijs, Marco J. ;
Brenton, James D. ;
Berns, Els M. J. J. ;
Helleman, Jozien .
PLOS ONE, 2014, 9 (09)
[5]   Therapeutic Inducers of Apoptosis in Ovarian Cancer [J].
Binju, Mudra ;
Amaya-Padilla, Monica Angelica ;
Wan, Graeme ;
Gunosewoyo, Hendra ;
Rahmanto, Yohan Suryo ;
Yu, Yu .
CANCERS, 2019, 11 (11)
[6]   Nuclear factor-κB, cancer, and apoptosis [J].
Bours, V ;
Bentires-Alj, M ;
Hellin, AC ;
Viatour, P ;
Robe, P ;
Delhalle, S ;
Benoit, V ;
Merville, MP .
BIOCHEMICAL PHARMACOLOGY, 2000, 60 (08) :1085-1089
[7]   LncRNAs in Ovarian Cancer Progression, Metastasis, and Main Pathways: ceRNA and Alternative Mechanisms [J].
Braga, Eleonora A. ;
Fridman, Marina, V ;
Moscovtsev, Alexey A. ;
Filippova, Elena A. ;
Dmitriev, Alexey A. ;
Kushlinskii, Nikolay E. .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (22) :1-44
[8]  
Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI [10.3322/caac.21492, 10.3322/caac.21609]
[9]   BMI1 As a Novel Target for Drug Discovery in Cancer [J].
Cao, Liangxian ;
Bombard, Jenelle ;
Cintron, Katherine ;
Sheedy, Josephine ;
Weetall, Marla L. ;
Davis, Thomas W. .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2011, 112 (10) :2729-2741
[10]   NCK1-AS1 promotes NCK1 expression to facilitate tumorigenesis and chemo-resistance in ovarian cancer [J].
Chang, Hua ;
Li, Baixue ;
Zhang, Xue ;
Meng, Xiangkai .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 522 (02) :292-299